The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology.

L, Xu; H, Chen; J, Chen; M, Han; H, Huang; Y, Lai; D, Liu; Q, Liu; T, Liu; M, Jiang; H, Ren; Y, Song; Z, Sun; J, Wang; D, Wu; D, Zhou; P, Zou; K, Liu; X, Huang

doi:10.1186/s13045-018-0564-x

Public

The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology.

Shared by NobleBlocks on Mar 2, 2018 • 12:00 AM UTC

Authors:

Xu L

Chen H

Chen J

Abstract

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is widely used to treat malignant hematological neoplasms and non-malignant hematological disorders. Approximately, 5000 allo-HSCT procedures are performed in China annually. Substantial progress has been made in haploidentical HSCT (HID...

Subject

China

Conditioning Regimen

Consensus

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!